Efficacy of adding neoadjuvant pembrolizumab to standard chemotherapy for triple-negative breast cancer: A systematic review and meta-analysis of real-world studies

Authors
Category Systematic review
JournalPAKISTAN JOURNAL OF MEDICAL SCIENCES
Year 2026
This article has no abstract
Epistemonikos ID: 7285f996a8987f1666b4b182ef9cc62444df03b9
First added on: Oct 11, 2026